HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice.

Abstract
Cysteinyl-leukotrienes (cysLTs) and thromboxane A(2) (TXA(2)) are important mediators in inflammatory lung diseases such as bronchial asthma and idiopathic pulmonary fibrosis (IPF). We examined the effects of inhaled KP-496, a novel dual antagonist of the cysLTs and TXA(2) receptors, on bleomycin-induced IPF in mice. Mice were intravenously injected bleomycin on day 0, and 0.5% of KP-496 was inhaled twice a day (30 min/time) for the entire experimental period. The effects of KP-496 were evaluated by the number of infiltrated cells in bronchoalveolar lavage fluid (BALF), hydroxyl-L-proline content in the lung, and histopathology. Analyses of BALF on days 7 and 21 revealed that inhaled KP-496 significantly decreased total cell numbers, macrophages, neutrophils, and eosinophils on both days. KP-496 significantly decreased hydroxyl-L-proline content in the lung on day 21. Histopathological analyses of lungs on day 21 demonstrated that KP-496 significantly suppressed inflammatory and fibrotic changes. Our results suggested that the suppression of cysLTs and TXA(2) pathways by KP-496 could control airway inflammation and pulmonary fibrosis, and that KP-496 could be a new therapeutic agent for lung diseases with inflammation and fibrogenesis such as IPF and chronic obstructive pulmonary disease.
AuthorsShigeo Kurokawa, Masahiro Suda, Toshiaki Okuda, Yoshihide Miyake, Yuzuru Matsumura, Masakazu Ishimura, Ryota Saito, Tsutomu Nakamura
JournalPulmonary pharmacology & therapeutics (Pulm Pharmacol Ther) Vol. 23 Issue 5 Pg. 425-31 (Oct 2010) ISSN: 1522-9629 [Electronic] England
PMID20457270 (Publication Type: Journal Article)
CopyrightCopyright 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzoates
  • KP-496
  • Leukotriene Antagonists
  • Receptors, Leukotriene
  • Receptors, Thromboxane A2, Prostaglandin H2
  • Thiazoles
  • Bleomycin
  • leukotriene D4 receptor
Topics
  • Administration, Inhalation
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, pharmacology)
  • Benzoates (administration & dosage, pharmacology)
  • Bleomycin
  • Bronchoalveolar Lavage Fluid (cytology)
  • Disease Models, Animal
  • Inflammation (metabolism, pathology, prevention & control)
  • Leukotriene Antagonists (administration & dosage, pharmacology)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Pulmonary Fibrosis (chemically induced, prevention & control)
  • Receptors, Leukotriene (metabolism)
  • Receptors, Thromboxane A2, Prostaglandin H2 (antagonists & inhibitors, metabolism)
  • Thiazoles (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: